Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cixutumumab monotherapy is not beneficial in phase II hepatocellular carcinoma trial

June 30, 2011

Encouraging phase I data presented on GDC-0068 and GDC-0941 in cancer

June 30, 2011

PSN-821 reduces energy intake in patients with obesity and type 2 diabetes

June 29, 2011

Preliminary phase I data suggest safety/activity of RO-4987655 in advanced/metastatic solid tumors

June 29, 2011

RG-7112 advances through clinical development for cancer

June 29, 2011

SK Chemicals' new 11-beta-HSD1 inhibitor SKI-2852 is active in models of diabetes

June 29, 2011

MORAb-004 is active in first-in-human study

June 29, 2011

NK-012 shows promising activity in phase II trial in sensitive relapsed SCLC

June 29, 2011

First-in-human study reveals activity of RAF-265 in melanoma

June 28, 2011

Blocking Smad1 phosphorylation may reduce diabetic nephropathy

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...